WARNING

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close [x]

PASSAGES study FOR Multiple Sclerosis patients 

A research study that will be used to evaluate the long-term safety of a specific MS treatment and other disease modifying therapies (DMT) in patients with MS newly started with the study medication Gilenya or Fingolimod.

Passages is a 5 year study that will provide an opportunity to learn more about the safety and satisfaction of MS Treatment with Fingolimod. 

Patients receive a remuneration for their participation. 

For more information contact Alonso Prusmack here.

Please send your patients to:

Dr. Rosa Tang, MD, MPH, MBA
MS Eye Care at The University Eye Institute
4901 Calhoun Rd, UH Entrance 2
Houston, Texas 77204
Phone: 713-942-2187
Fax: 713-942-0265

Call to schedule an appointment or download this form and fax or e-mail it to us!

Kindly write PASSAGES study FOR Multiple Sclerosis patients under referral reason.

Exclusive Offer

THIS ---->https://neuroeye.imatrixbase.com/clinical-trials/thyroid-eye-disease.html

Office Hours

DayMorningAfternoon
Monday9 AM4 PM
Tuesday9 AM4 PM
Wednesday9 AM4 PM
Thursday9 AM4 PM
Friday9 AM4 PM
SaturdayClosedClosed
SundayClosedClosed
Day Morning Afternoon
Monday Tuesday Wednesday Thursday Friday Saturday Sunday
9 AM 9 AM 9 AM 9 AM 9 AM Closed Closed
4 PM 4 PM 4 PM 4 PM 4 PM Closed Closed

Newsletter Sign Up